| 综述 |
|
|
|
|
| 体液循环microRNA的研究进展 |
| 满朝来1, 杨美玲2 |
1. 哈尔滨师范大学生命科学与技术学院 黑龙江省分子细胞遗传与遗传育种重点实验室 哈尔滨 150025;
2. 哈尔滨工业大学生命科学与技术学院 哈尔滨 150001 |
|
| Research Progress in Circulating MicroRNAs of Body Fluid |
| MAN Chao-lai1, YANG Mei-ling2 |
1. Key Laboratory of Molecular Cytogenetics and Genetic Breeding of Heilongjiang Province, College of Life Science and Technology, Harbin Normal University, Harbin 150025, China;
2. College of Life Science and Technology, Harbin Institute of Technology, Harbin 150025, China |
| [1] Coulouarn C, Factor V M, Andersen J B, et al. Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties. Oncogene, 2009, 28(40): 3526-3536.
[2] Wang G K, Zhu J Q, Zhang J T, et al. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J, 2010, 31(6): 659-666.
[3] Iguchi H, Kosaka N, Ochiya T. Secretory microRNAs as a versatile communication tool. Commun Integr Biol, 2010, 3(5): 478-481.
[4] Ogawa R, Tanaka C, Sato M, et al. Adipocyte-derived microvesicles contain RNA that is transported into macrophages and might be secreted into blood circulation. Biochem Biophys Res Commun, 2010, 398(4): 723-729.
[5] Hunter M P, Ismail N, Zhang X, et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS One, 2008, 3(11): e3694.
[6] Taylor D D, Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol, 2008, 110(1): 13-21.
[7] Skog J, Würdinger T, van Rijn S, et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol, 2008, 10(12): 1470-1476.
[8] Zhang L, Hou D, Chen X, et al. Exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNA. Cell Res, 2012, 22(1):107-126.
[9] Orozco A F, Lewis D E. Flow cytometric analysis of circulating microparticles in plasma. Cytometry A, 2010, 77(6): 502-514.
[10] Février B, Raposo G. Exosomes: endosomal-derived vesicles shipping extracellular messages. Curr Opin Cell Biol, 2004,16(4): 415-421.
[11] Zomer A, Vendrig T, Hopmans E S, et al. Exosomes: Fit to deliver small RNA. Commun Integr Biol, 2010, 3(5): 447-450.
[12] Simpson R J, Lim J W, Moritz R L, et al. Exosomes: proteomic insights and diagnostic potential. Expert Rev Proteomics, 2009, 6(3): 267-283.
[13] Arroyo J D, Chevillet J R, Kroh E M, et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A, 2011, 108(12): 5003-5008.
[14] Turchinovich A, Weiz L, Langheinz A, et al. Characterization of extracellular circulating microRNA. Nucleic Acids Res, 2011, 39(16): 7223-7233.
[15] Vickers K C, Palmisano B T, Shoucri B M, et al. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol, 2011, 13(4): 423-433.
[16] Wang K, Zhang S, Weber J, et al. Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res, 2010, 38(20): 7248-7259.
[17] Kroh E M, Parkin R K, Mitchell P S, et al. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods, 2010, 50(4): 298-301.
[18] Hanson E K, Ballantyne J. Circulating microRNA for the identification of forensically relevant body fluids. Methods Mol Biol, 2013, 1024: 221-234.
[19] He S, Chu J, Wu L C, et al. MicroRNAs activate natural killer cells through Toll-like receptor signaling. Blood, 2013, 121(23): 4663-4671.
[20] Fabbri M, Paone A, Calore F, et al. MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proc Natl Acad Sci U S A, 2012, 109(31): E2110-2116.
[21] Miao C G, Yang Y Y, He X, et al. The emerging role of microRNAs in the pathogenesis of systemic lupus erythematosus. Cell Signal, 2013, 25(9):1828-1836.
[22] Fichtlscherer S, Zeiher A M, Dimmeler S. Circulating microRNAs: biomarkers or mediators of cardiovascular diseases? Arterioscler Thromb Vasc Biol, 2011, 31(11): 2383-2390.
[23] Mo M H, Chen L, Fu Y, et al. Cell-free circulating miRNA biomarkers in cancer. J Cancer, 2012, 3: 432-448.
[24] Allegra A, Alonci A, Campo S, et al. Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer. Int J Oncol, 2012, 41(6):1897-1912.
[25] van Empel V P, De Windt L J, da Costa Martins P A. Circulating miRNAs: reflecting or affecting cardiovascular disease? Curr Hypertens Rep, 2012, 14(6): 498-509.
[26] Tijsen A J, Pinto Y M, Creemers E E. Circulating microRNAs as diagnostic biomarkers for cardiovascular diseases. Am J Physiol Heart Circ Physiol, 2012, 303(9):1085-1095.
[27] Creemers E E, Tijsen A J, Pinto Y M. Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? Circ Res, 2012, 110(3): 483-495.
[28] Weber J A, Baxter D H, Zhang S, et al. The microRNA spectrum in 12 body fluids. Clin Chem, 2010, 56(11): 1733-1741.
[29] Kosaka N, Izumi H, Sekine K, et al. microRNA as a new immune-regulatory agent in breast milk. Silence, 2010,1(1): 7.
[30] Igaz P, Nagy Z, Vásárhelyi B, et al. Potential role for microRNAs in inter-individual and inter-species communication. Orv Hetil, 2012, 153(42):1647-1650. |
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
| |
Shared |
|
|
|
|
| |
Discussed |
|
|
|
|
